Next Article in Journal
Efficient Removal of Copper Ion from Wastewater Using a Stable Chitosan Gel Material
Next Article in Special Issue
Lectin PLL3, a Novel Monomeric Member of the Seven-Bladed β-Propeller Lectin Family
Previous Article in Journal
Effects of GGT and C-S Lyase on the Generation of Endogenous Formaldehyde in Lentinula edodes at Different Growth Stages
Previous Article in Special Issue
Lectin-Based Method for Deciphering Human Milk IgG Sialylation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

CNL–Clitocybe nebularis Lectin—The Fungal GalNAcβ1-4GlcNAc-Binding Lectin

1
Department of Biotechnology, Jožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia
2
Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia
*
Author to whom correspondence should be addressed.
Molecules 2019, 24(23), 4204; https://doi.org/10.3390/molecules24234204
Submission received: 27 October 2019 / Revised: 15 November 2019 / Accepted: 15 November 2019 / Published: 20 November 2019

Abstract

:
Clitocybe nebularis lectin (CNL) is present in fruiting bodies of clouded agaric along with several similar isolectins that are all small and stable proteins. It is a beta-trefoil type lectin forming homodimers that are essential for its functionality. It binds specifically N,N′-diacetyllactosediamine (GalNAcβ1-4GlcNAc, LacDiNac) and human blood group A determinant-containing glycan epitopes. Its most probable function is to defend fruiting bodies against predators and parasites. In addition, an endogenous regulatory function is possible for CNL, as indicated by its interaction with fungal protease inhibitors sharing the beta-trefoil fold. CNL is toxic to insects, nematodes and amoebae, as well as to leukemic T-cell lines. Bivalent carbohydrate binding is essential for the toxicity of CNL, against both invertebrates and cancer-derived cell lines. In addition, CNL exhibits potent immunostimulation of human dendritic cells, resulting in a strong T helper cell type 1 response. Based on its unique characteristics, CNL is a promising candidate for applications in human and veterinary medicine as well as in agriculture, for plant protection.

Graphical Abstract

1. Introduction

Clitocybe nebularis lectin (CNL) is one of many lectins identified in fruiting bodies of clouded agaric (Clitocybe nebularis) mushroom. They are small and stable proteins that display a variety of glycan binding specificities [1,2]. Obtaining the gene coding for CNL enabled production of the recombinant protein and, hence, detailed structural and functional analysis [3,4]. CNL is a hololectin that forms homodimers, which is essential for its functionality. Structural analysis revealed it to be a β-trefoil-type lectin. Glycan microarray analysis confirmed its specific binding of terminal GalNAc, preferentially in the context of N,N′-diacetyllactosediamine (GalNAcβ1-4GlcNAc, LacDiNac) and human blood group A determinant-containing glycan epitopes (Table 1), as well as weaker binding of other β-galactosides [3,4]. By the presence of specific target glycans on nematodes and cancer cells it was confirmed that CNL is nematotoxic and specifically cytotoxic for leukemic T-cells [4,5].
In this review an overview of current knowledge about CNL is provided, including a description of its structure, its mechanism of action, and the potential for its application.

2. CNL Structure

CNL is a β-trefoil-type lectin, as was predicted from the cDNA-deduced amino acid sequence (Figure 1) and based on the presence of the conserved QxW motif and the non-polar residues important for the hydrophobic core of the fold [3]. The β-trefoil fold is one of the most prevalent hololectin family folds present in higher fungi [6]. Twelve β-strands, forming three structurally similar repeats named α, β, and γ repeats, are related by pseudo-3-fold symmetry and form a six-stranded β-barrel (Figure 2). The signature QxW motif is conserved in the α and γ repeat, while it is absent from the β repeat of CNL and other similar fungal lectins (Figure 1). High sequence divergence is common for the β-trefoil fold as the major sequence requirement of the fold is the presence of 18 hydrophobic residues at distinct sites within the molecule that stabilize the barrel structure. The 12 β-strands are connected by loops differing greatly in sequence and length that constitute more than half of the molecule [4,7,8]. In CNL only the α repeat harbors a functional carbohydrate binding site, in which β2 and β3 strands form the bottom of the shallow binding pocket and are surrounded by β2-β3 and β3-β4 loops [4].
The fungal β-trefoil fold lectins show very high sequence variability (Figure 1). They overall share only 7% to 16% sequence identity (25% to 35% similarity) among the representatives that have been thoroughly characterized, including MpL (Macrolepiota procera lectin) [9], CCL2 (Coprinopsis cinerea lectin 2) [10], RSA (Rhizoctonia solani agglutinin) [11], SSA (Sclerotinia sclerotiorum agglutinin) [12], and BEL β-trefoil (Boletus edulis lectin β-trefoil) [13]. Lectins CNL, MpL, and RSA are exceptions as they share 23% to 26%identity (30% to 40% similarity). Interestingly, these proteins with the same 3D structure form dimers through different interfaces resulting in carbohydrate binding sites positioned on the opposite faces of the dimer (CNL and RSA) or on one face of the dimer (CCL2 and SSA), while BEL β-trefoil binds carbohydrates in all canonical binding sites [4,12,13,14,15].
Opposite the carbohydrate binding site lies the dimer interface area (Figure 3). The dimer is formed by interaction of the two β4-β5 loops through exclusively hydrophobic interactions and of the two β9-β10 loops through two hydrogen bonds. A double mutation was required to abolish dimerization, one that prevented the formation of hydrogen bonds (Asn110 to Asp) in β9-β10 loops and the other to disrupt the hydrophobic interactions (Leu54 to Arg or Trp) in β4-β5 loops. These monomeric mutants retained regular carbohydrate binding activity [4].

3. CNL Function

The biological function of CNL is probably to protect fruiting bodies against predators, grazers, and parasites. It has been shown to be toxic toward insects, nematodes, and amoebozoa [1,3,5].

3.1. CNL Function in Fruiting Body Defense

The small size of the protein, its solubility, and its resistance to high temperatures, extreme pH and proteolytic degradation are features associated with proteins known to be involved in fungal fruiting body defense [6]. Furthermore, several characteristics that CNL shares with other fungal fruiting body lectins indicate its cytoplasmic localization. Thus, no signal sequence for classical secretion is encoded in the CNL gene; CNL does not contain any cysteine residues and is not glycosylated. CNL is modified post-translationally by acetylation of its N-terminus [3,5,6]. In addition, it can interact with fungal protease inhibitors sharing the β-trefoil fold, modulating their activity. It is particularly interesting that CNL interacts with the trypsin-specific protease inhibitor cnispin, which is also expressed in fruiting bodies of C. nebularis [16,17]. Complex formation between CNL and cnispin has been demonstrated by glutaraldehyde cross-linking in vitro [17]. Moreover, cnispin inhibits the hemagglutination of human erythrocytes by CNL. Conversely, CNL did not prevent trypsin inhibition by cnispin in vitro, but did counter the activity of a similar trypsin-specific protease inhibitor, cospin, from Coprinopsis cinerea [17,18,19]. The interaction, with modulation of each other’s activity, suggests an important endogenous regulatory function, for both the CNL lectin and the protease inhibitors, that could also affect inter-organism interactions. Furthermore, the CNL and the protease inhibitors cnispin and cospin target non-endogenous glycan structures and proteases, respectively, indicating their roles in the defense of fruiting bodies [4,16,17,19].

3.2. The CNL Target Glycan

The CNL target glycan, LacDiNAc (Figure 4), is present abundantly in insects and parasitic helminths [20,21]. A negative effect on the development of insect larvae by CNL was therefore expected, and has been confirmed for the fruit fly (Drosophila melanogaster), mosquito (Aedes aegypti), and Colorado potato beetle (Leptinotarsa decemlineata) [1,5]. Furthermore, CNL showed moderate toxicity toward the amoebozoan Acanthamoeba castellanii and was toxic only to the pmk-1 mutant of the model nematode Caenorhabditis elegans that is hypersensitive toward a variety of stresses due to a defect in the p38 MAPK pathway [5].
The LacDiNAc terminal group is also found in N- and O-glycans of vertebrates, however it is rarely present in mammalian glycoproteins. It has been shown to play important roles in the regulation of half-life of the circulating glycohormone lutropin and in the functional differentiation of mammary epithelial cells. Furthermore, LacdiNAc on the non-reducing termini of N-glycans of cell surface glycoproteins significantly decreases or increases according to the progression stages of human cancers, making it a potentially useful biomarker for different types of cancer and their progression [22,23].
Only one other well characterized lectin that specifically binds the LacDiNac disaccharide has been described and this is Wisteria floribunda agglutinin (WFA) that belongs to leguminous lectin family and shares the fold with the well-known plant lectin ConA (Concanavalin A) that requires tightly bound calcium and manganese ions for interaction with carbohydrates [24,25].

4. Mechanisms of CNL Functions

4.1. Mechanism of Carbohydrate Binding

LacDiNAc binds to the carbohydrate binding pocket of the α repeat by six hydrogen bonds (Figure 5). Five are formed between four amino acid residues in CNL and two hydroxyl groups of galactose and the sixth between amino acid residue Ser24 in CNL and the N-acetyl group of GalNAc. Asp20, which is positioned at the bottom of the binding pocket, anchors the galactose by forming two hydrogen bonds with the O3 and O4 atoms of galactose. Further, the O3 atom forms two additional hydrogen bonds to amide nitrogen atoms in the side chains of residues Asn38 and Asn46, while the O4 atom forms a hydrogen bond with the amide nitrogen in Gly23. Additional water-mediated hydrogen bonds are also formed (Figure 5b). Lactose binds in the same way, through the five hydrogen bonds formed by galactose, however they are, in general, longer than those in structures of CNL in complex with LacDiNAc. The carbohydrate binding site is effectively inactivated by the single mutation of Asp20 to Arg, whose long side chain fills the binding pocket and prevents carbohydrate docking.
Glycan microarray analysis confirmed the higher affinity of CNL for LacDiNAc than for lactose. Additional quantitative binding data for these and other similar carbohydrates will be indispensable for further understanding of the binding affinity. Furthermore, recombinant CNL shows a more restricted specificity for LacDiNAc than the natural CNL isolated from C. nebularis fruiting bodies. This broader specificity is most probably the consequence of sequence heterogeneity in isolates of natural CNL that probably comprise multiple isolectins differing slightly in their carbohydrate binding specificities [3,4]. Limited sequence heterogeneity, resulting in considerable changes in function, was also shown for the fungal protease inhibitors with β-trefoil fold, mycocypins and mycospins [18,26,27,28].
The binding of LacDiNAc to WFA is similar to that of CNL as hydrogen bonds are formed exclusively to the GalNAc moiety of the disaccharide, however, seven hydrogen bonds are formed between WFA and GalNAc compared to the six in CNL. Similarly, indirect hydrogen bonds via water molecules and hydrophobic interactions are reported resulting in larger buried surface area of the GlcNAc moiety in LacDiNAc binding [25].

4.2. Mechanisms of Entomotoxicity, Nematotoxicity, and Leukemic T-Cell Toxicity

The entomotoxicity of CNL is dependent on carbohydrate binding, since the addition of lactose during toxicity tests abolished toxicity of CNL toward D. melanogaster larvae [1]. Using the non-carbohydrate-binding mutant CNL Asp20Arg, the indispensability of carbohydrate binding was confirmed for nematotoxicity also. However, carbohydrate binding is not sufficient and, using non-dimerizing CNL mutants, it was shown that CNL dimerization is equally important for nematotoxicity. The bivalent carbohydrate binding is, therefore, essential for CNL activity, suggesting that CNL toxicity is mediated by cross-linking of glycoligands thus, most probably, triggering a signaling pathway (Figure 6) [4].
The exact mechanism of toxicity has not yet been determined for CNL, however, studies of toxicity mechanisms of other fungal β-trefoil lectins indicate a similar mechanism for all. Binding of RSA to intestinal epithelial cells is necessary for entomotoxicity of RSA, where it is not internalized but intoxicated epithelial cells show symptoms of apoptosis, possibly caused by lectin-mediated activation of the respective signaling pathways [11,30,31]. Similarly, the entomotoxicity of SSA depends on its binding to insect midgut epithelial cells and triggering their death probably via a signal transduction pathway as it is not internalized [32]. In addition, glycan binding is essential for nematotoxicity of CCL2 and is similarly mediated by binding to nematode intestinal epithelium without being endocytosed and leading to disintegration of microvillar organization [6,10,33].
CNL exhibits an antiproliferative effect exclusively on leukemic T-cell lines, e.g., Jurkat, in a dose-dependent manner [3]. Similar to invertebrate toxicity, bivalent carbohydrate binding is essential for the cytotoxicity of CNL against leukemic T-cells (Figure 6). Preincubation of CNL with lactose, or the use of a non-carbohydrate-binding mutant of CNL, abolished the cytotoxic effect. Furthermore, using a non-dimerizing mutant in cytotoxicity analyses showed that only an active dimer can cause the toxic effect [4]. Several other lectins isolated from mushrooms have shown antiproliferative activity against different human cell lines [34]. Among the other mentioned β-trefoil fold lectins from mushrooms, RSA and SSA were shown to exhibit antiproliferative effect in cell lines, but it was only tested against insect-derived cell lines [30,32]. The antiproliferative effect of the BEL β-trefoil lectin exhibited different degrees against nine different human cancer cell lines. It most strongly inhibited the proliferation of the HepG-2 hepatocellular carcinoma cells followed by the CaCo-2 human colorectal adenocarcinoma and MCF-7 breast cancer cell lines. Carbohydrate binding and internalization into cells were shown to be important for the antiproliferative effect [13]. On the other hand, MpL was shown not to be toxic to eight different mammalian cell lines despite entering the cell via endocytosis. MpL also acted as a vehicle for internalization of associated proteins and accumulated in lysosomes [35].

4.3. Mechanism of Dendritic Cell Activation

CNL strongly stimulates maturation of dendritic cells (DCs) that are the dominant antigen-presenting cells in humans [36]. DCs are key regulators of both protective immune responses and tolerance to self-antigens. The maturation of DCs is a complex process characterized by the acquisition of a number of fundamental properties: Antigen processing and presentation, migration and T-cell co-stimulation. DCs display morphological, phenotypic, and functional variability, enabling their control of both immunity and tolerance, depending on their activation status and the microenvironment. Triggering of Toll-like receptors on DCs is thought to be critical for their functional maturation to immunogenic DCs and the priming of naïve T-cells in response to infection, and therefore coupling innate and adaptive immunity [37]. Stimulation of DC maturation by CNL is activated through the Toll-like receptor 4 (TLR4) pathway and induces activation of NF-κB and, also, p38 MAPK signaling. This results in mature DCs capable of generating a strong T helper type 1 (Th1)-polarized T-cell response. Th1 T-cells support and maintain cellular immune responses that effectively counter invading pathogens and cancer pathologies [36].

5. Conclusions

CNL possesses unique characteristics that make it a promising candidate for applications in medicine, biotechnology, and agriculture. Based on its distinct carbohydrate-binding specificity it could find a use in diagnostic and therapeutic applications in medicine, particularly for immunotherapy, and especially for specific targeting of leukemic T-cells and for treating T-cell mediated autoimmune and inflammatory disorders as well as hematopoietic malignancies. Further, in addition to its application in clinical diagnostics, CNL could be used in basic medical and biotechnological research, including analysis of malignant transformations and altered glycosylation patterns during tumor progression and metastasis, employing microarray analysis, lectin-based biosensors or affinity chromatography. Finally, based on its nematotoxicity and entomotoxicity, CNL could be used in plant protection against pathogens and pests or in veterinary and human medicine against parasites [2,6,38].

Author Contributions

J.S. wrote the original draft and J.K. reviewed and edited the manuscript.

Funding

This work was supported by the Slovenian Research Agency Grant No. P4-0127 (to J.K.)

Acknowledgments

We are grateful to the many researchers who, over the years, have contributed to knowledge on CNL, and especially, to Jože Brzin who initiated the Clitocybe lectins research, to Jure Pohleven who performed the largest share of the research, to Simon Žurga who continued in his steps, and to Miha Renko who performed all structural analyses. We thank Roger H. Pain for critical reading and English improvement.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Pohleven, J.; Brzin, J.; Vrabec, L.; Leonardi, A.; Čokl, A.; Štrukelj, B.; Kos, J.; Sabotič, J. Basidiomycete Clitocybe nebularis is rich in lectins with insecticidal activities. Appl. Microbiol. Biotechnol. 2011, 91, 1141–1148. [Google Scholar] [CrossRef] [PubMed]
  2. Pohleven, J.; Kos, J.; Sabotič, J. Medicinal properties of the genus Clitocybe and of lectins from clouded funnel cap, Clitocybe nebularis (Batsch) P. Kumm. (Tricholomataceae): A review. Int. J. Med. Mushrooms 2016, 18, 1153–1159. [Google Scholar] [CrossRef] [PubMed]
  3. Pohleven, J.; Obermajer, N.; Sabotič, J.; Anžlovar, S.; Sepčić, K.; Kos, J.; Kralj, B.; Štrukelj, B.; Brzin, J. Purification, characterization and cloning of a ricin B-like lectin from mushroom Clitocybe nebularis with antiproliferative activity against human leukemic T cells. Biochim. Et Biophys. Acta (Bba)—Gen. Subj. 2009, 1790, 173–181. [Google Scholar] [CrossRef] [PubMed]
  4. Pohleven, J.; Renko, M.; Magister, S.; Smith, D.F.; Kunzler, M.; Strukelj, B.; Turk, D.; Kos, J.; Sabotic, J. Bivalent carbohydrate binding is required for biological activity of Clitocybe nebularis lectin (CNL), the N,N′-diacetyllactosediamine (GalNAcbeta1-4GlcNAc, LacdiNAc)-specific lectin from basidiomycete C. nebularis. J. Biol. Chem. 2012, 287, 10602–10612. [Google Scholar] [CrossRef] [PubMed]
  5. Bleuler-Martínez, S.; Butschi, A.; Garbani, M.; Wälti, M.A.; Wohlschlager, T.; Potthoff, E.; Sabotič, J.; Pohleven, J.; Lüthy, P.; Hengartner, M.O.; et al. A lectin-mediated resistance of higher fungi against predators and parasites. Mol. Ecol. 2011, 20, 3056–3070. [Google Scholar] [CrossRef]
  6. Sabotič, J.; Ohm, R.A.; Künzler, M. Entomotoxic and nematotoxic lectins and protease inhibitors from fungal fruiting bodies. Appl. Microbiol. Biotechnol. 2016, 100, 91–111. [Google Scholar] [CrossRef]
  7. Murzin, A.G.; Lesk, A.M.; Chothia, C. beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors. J. Mol. Biol. 1992, 223, 531–543. [Google Scholar] [CrossRef]
  8. Renko, M.; Sabotič, J.; Turk, D. β-Trefoil inhibitors—From the work of Kunitz onward. Biol. Chem. 2012, 393, 1043. [Google Scholar] [CrossRef]
  9. Žurga, S.; Pohleven, J.; Renko, M.; Bleuler-Martínez, S.; Sosnowski, P.; Turk, D.; Künzler, M.; Kos, J.; Sabotič, J. A novel beta-trefoil lectin from the parasol mushroom (Macrolepiota procera) is nematotoxic. Febs J. 2014, 281, 3489–3506. [Google Scholar] [CrossRef]
  10. Schubert, M.; Bleuler-Martinez, S.; Butschi, A.; Wälti, M.A.; Egloff, P.; Stutz, K.; Yan, S.; Wilson, I.B.H.; Hengartner, M.O.; Aebi, M.; et al. Plasticity of the β-Trefoil Protein Fold in the Recognition and Control of Invertebrate Predators and Parasites by a Fungal Defence System. PLoS Pathog. 2012, 8, e1002706. [Google Scholar] [CrossRef]
  11. Hamshou, M.; Van Damme, E.J.; Caccia, S.; Cappelle, K.; Vandenborre, G.; Ghesquiere, B.; Gevaert, K.; Smagghe, G. High entomotoxicity and mechanism of the fungal GalNAc/Gal-specific Rhizoctonia solani lectin in pest insects. J. Insect Physiol. 2013, 59, 295–305. [Google Scholar] [CrossRef] [PubMed]
  12. Sulzenbacher, G.; Roig-Zamboni, V.; Peumans, W.J.; Rougé, P.; Van Damme, E.J.M.; Bourne, Y. Crystal Structure of the GalNAc/Gal-Specific Agglutinin from the Phytopathogenic Ascomycete Sclerotinia sclerotiorum Reveals Novel Adaptation of a β-Trefoil Domain. J. Mol. Biol. 2010, 400, 715–723. [Google Scholar] [CrossRef] [PubMed]
  13. Bovi, M.; Cenci, L.; Perduca, M.; Capaldi, S.; Carrizo, M.E.; Civiero, L.; Chiarelli, L.R.; Galliano, M.; Monaco, H.L. BEL β-trefoil: A novel lectin with antineoplastic properties in king bolete (Boletus edulis) mushrooms. Glycobiology 2013, 23, 578–592. [Google Scholar] [CrossRef]
  14. Bleuler-Martinez, S.; Stutz, K.; Sieber, R.; Collot, M.; Mallet, J.M.; Hengartner, M.; Schubert, M.; Varrot, A.; Kunzler, M. Dimerization of the fungal defense lectin CCL2 is essential for its toxicity against nematodes. Glycobiology 2017, 27, 486–500. [Google Scholar] [CrossRef] [PubMed]
  15. Skamnaki, V.T.; Peumans, W.J.; Kantsadi, A.L.; Cubeta, M.A.; Plas, K.; Pakala, S.; Zographos, S.E.; Smagghe, G.; Nierman, W.C.; Van Damme, E.J.; et al. Structural analysis of the Rhizoctonia solani agglutinin reveals a domain-swapping dimeric assembly. Febs J. 2013, 280, 1750–1763. [Google Scholar] [CrossRef]
  16. Avanzo, P.; Sabotič, J.; Anžlovar, S.; Popovič, T.; Leonardi, A.; Pain, R.H.; Kos, J.; Brzin, J. Trypsin-specific inhibitors from the basidiomycete Clitocybe nebularis with regulatory and defensive functions. Microbiology 2009, 155, 3971–3981. [Google Scholar] [CrossRef]
  17. Žurga, S.; Pohleven, J.; Kos, J.; Sabotič, J. beta-Trefoil structure enables interactions between lectins and protease inhibitors that regulate their biological functions. J. Biochem. 2015, 158, 83–90. [Google Scholar] [CrossRef]
  18. Avanzo Caglič, P.; Renko, M.; Turk, D.; Kos, J.; Sabotič, J. Fungal beta-trefoil trypsin inhibitors cnispin and cospin demonstrate the plasticity of the beta-trefoil fold. Biochim. Et Biophys. Acta 2014, 1844, 1749–1756. [Google Scholar] [CrossRef]
  19. Sabotič, J.; Bleuler-Martínez, S.; Renko, M.; Avanzo Caglič, P.; Kallert, S.; Štrukelj, B.; Turk, D.; Aebi, M.; Kos, J.; Künzler, M. Structural Basis of Trypsin Inhibition and Entomotoxicity of Cospin, Serine Protease Inhibitor Involved in Defense of Coprinopsis cinerea Fruiting Bodies. J. Biol. Chem. 2012, 287, 3898–3907. [Google Scholar] [CrossRef]
  20. Sasaki, N.; Yoshida, H.; Fuwa, T.J.; Kinoshita-Toyoda, A.; Toyoda, H.; Hirabayashi, Y.; Ishida, H.; Ueda, R.; Nishihara, S. Drosophila beta 1,4-N-acetylgalactosaminyltransferase-A synthesizes the LacdiNAc structures on several glycoproteins and glycosphingolipids. Biochem. Biophys. Res. Commun. 2007, 354, 522–527. [Google Scholar] [CrossRef]
  21. Van den Eijnden, D.H.; Neeleman, A.P.; Van der Knaap, W.P.; Bakker, H.; Agterberg, M.; Van Die, I. Novel glycosylation routes for glycoproteins: The lacdiNAc pathway. Biochem. Soc. Trans. 1995, 23, 175–179. [Google Scholar] [CrossRef] [PubMed]
  22. Hirano, K.; Matsuda, A.; Shirai, T.; Furukawa, K. Expression of LacdiNAc groups on N-glycans among human tumors is complex. Biomed. Res. Int. 2014, 2014, 981627. [Google Scholar] [CrossRef] [PubMed]
  23. Hirano, K.; Takada, Y.; Furukawa, K. LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells. Histochem. Cell Biol. 2019. [Google Scholar] [CrossRef] [PubMed]
  24. Sato, T.; Tateno, H.; Kaji, H.; Chiba, Y.; Kubota, T.; Hirabayashi, J.; Narimatsu, H. Engineering of recombinant Wisteria floribunda agglutinin specifically binding to GalNAcbeta1,4GlcNAc (LacdiNAc). Glycobiology 2017. [Google Scholar] [CrossRef]
  25. Haji-Ghassemi, O.; Gilbert, M.; Spence, J.; Schur, M.J.; Parker, M.J.; Jenkins, M.L.; Burke, J.E.; van Faassen, H.; Young, N.M.; Evans, S.V. Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[beta1-4]GlcNAc), by Wisteria floribunda Agglutinin. J. Biol. Chem. 2016, 291, 24085–24095. [Google Scholar] [CrossRef]
  26. Renko, M.; Sabotič, J.; Mihelič, M.; Brzin, J.; Kos, J.; Turk, D. Versatile loops in mycocypins inhibit three protease families. J. Biol. Chem. 2010, 285, 308–316. [Google Scholar] [CrossRef]
  27. Sabotič, J.; Gaser, D.; Rogelj, B.; Gruden, K.; Štrukelj, B.; Brzin, J. Heterogeneity in the cysteine protease inhibitor clitocypin gene family. Biol. Chem. 2006, 387, 1559–1566. [Google Scholar] [CrossRef]
  28. Sabotič, J.; Popovič, T.; Puizdar, V.; Brzin, J. Macrocypins, a family of cysteine protease inhibitors from the basidiomycete Macrolepiota procera. Febs J. 2009, 276, 4334–4345. [Google Scholar] [CrossRef]
  29. Wallace, A.C.; Laskowski, R.A.; Thornton, J.M. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 1995, 8, 127–134. [Google Scholar] [CrossRef]
  30. Hamshou, M.; Van Damme, E.J.; Vandenborre, G.; Ghesquiere, B.; Trooskens, G.; Gevaert, K.; Smagghe, G. GalNAc/Gal-binding Rhizoctonia solani agglutinin has antiproliferative activity in Drosophila melanogaster S2 cells via MAPK and JAK/STAT signaling. PLoS ONE 2012, 7, e33680. [Google Scholar] [CrossRef]
  31. Walski, T.; Van Damme, E.J.; Smagghe, G. Penetration through the peritrophic matrix is a key to lectin toxicity against Tribolium castaneum. J. Insect Physiol. 2014, 70, 94–101. [Google Scholar] [CrossRef] [PubMed]
  32. Hamshou, M.; Smagghe, G.; Shahidi-Noghabi, S.; De Geyter, E.; Lannoo, N.; Van Damme, E.J. Insecticidal properties of Sclerotinia sclerotiorum agglutinin and its interaction with insect tissues and cells. Insect Biochem. Mol. Biol. 2010, 40, 883–890. [Google Scholar] [CrossRef] [PubMed]
  33. Stutz, K.; Kaech, A.; Aebi, M.; Kunzler, M.; Hengartner, M.O. Disruption of the C. elegans Intestinal Brush Border by the Fungal Lectin CCL2 Phenocopies Dietary Lectin Toxicity in Mammals. PLoS ONE 2015, 10, e0129381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Hassan, M.A.; Rouf, R.; Tiralongo, E.; May, T.W.; Tiralongo, J. Mushroom lectins: Specificity, structure and bioactivity relevant to human disease. Int. J. Mol. Sci. 2015, 16, 7802–7838. [Google Scholar] [CrossRef] [Green Version]
  35. Žurga, S.; Perišić Nanut, M.; Kos, J.; Sabotič, J. Fungal lectin MpL enables entry of protein drugs into cancer cells and their subcellular targeting. Oncotarget 2017. [Google Scholar] [CrossRef] [Green Version]
  36. Švajger, U.; Pohleven, J.; Kos, J.; Štrukelj, B.; Jeras, M. CNL, a ricin B-like lectin from mushroom Clitocybe nebularis, induces maturation and activation of dendritic cells via the toll-like receptor 4 pathway. Immunology 2011, 134, 409–418. [Google Scholar] [CrossRef] [Green Version]
  37. Dalod, M.; Chelbi, R.; Malissen, B.; Lawrence, T. Dendritic cell maturation: Functional specialization through signaling specificity and transcriptional programming. Embo J. 2014, 33, 1104–1116. [Google Scholar] [CrossRef]
  38. Erjavec, J.; Kos, J.; Ravnikar, M.; Dreo, T.; Sabotič, J. Proteins of higher fungi—From forest to application. Trends Biotechnol. 2012, 30, 259–273. [Google Scholar] [CrossRef]
Sample Availability: Samples of the CNL lectin are available from the authors.
Figure 1. Amino acid sequence alignment of selected fungal β-trefoil fold lectins. Identical residues in at least four of the six sequences (60%) are highlighted in dark grey and similar residues are highlighted in light grey. The alignment was carried out using ClustalW with the BLOSUM62 matrix. The β-sheets of the secondary structure are indicated by lines above the sequences and the QxW motif is indicated by three asterisks below the sequence in each repeat. Amino acid residues involved in LacDiNAc binding are in red boldface and those involved in dimer formation are in blue.
Figure 1. Amino acid sequence alignment of selected fungal β-trefoil fold lectins. Identical residues in at least four of the six sequences (60%) are highlighted in dark grey and similar residues are highlighted in light grey. The alignment was carried out using ClustalW with the BLOSUM62 matrix. The β-sheets of the secondary structure are indicated by lines above the sequences and the QxW motif is indicated by three asterisks below the sequence in each repeat. Amino acid residues involved in LacDiNAc binding are in red boldface and those involved in dimer formation are in blue.
Molecules 24 04204 g001
Figure 2. CNL three-dimensional (3D)-structure (PDB ID: 3NBD). (a) Structure of the CNL monomer that adopts the β-trefoil fold consisting of three repeats and shown in the following colors: α-repeat, red; β-repeat, green; γ-repeat, blue. (b) The solvent-accessible surface of CNL monomer in the same position as in (a). (c) The solvent-accessible surface area of CNL dimer showing monomers related by pseudo 2-fold rotational symmetry. The three repeats are colored as in (a). Lactose bound at the binding site on α-repeat is shown in magenta.
Figure 2. CNL three-dimensional (3D)-structure (PDB ID: 3NBD). (a) Structure of the CNL monomer that adopts the β-trefoil fold consisting of three repeats and shown in the following colors: α-repeat, red; β-repeat, green; γ-repeat, blue. (b) The solvent-accessible surface of CNL monomer in the same position as in (a). (c) The solvent-accessible surface area of CNL dimer showing monomers related by pseudo 2-fold rotational symmetry. The three repeats are colored as in (a). Lactose bound at the binding site on α-repeat is shown in magenta.
Molecules 24 04204 g002
Figure 3. CNL dimer. The dimer interface comprises hydrophobic interactions between the β4 and β5 loops, shown in red, that involve residues Val52, Leu54, Pro55, and Ile59 and hydrogen bonds in the β9-β10 loops, shown in blue, that involve residues Pro109 and Asn110 from each loop.
Figure 3. CNL dimer. The dimer interface comprises hydrophobic interactions between the β4 and β5 loops, shown in red, that involve residues Val52, Leu54, Pro55, and Ile59 and hydrogen bonds in the β9-β10 loops, shown in blue, that involve residues Pro109 and Asn110 from each loop.
Molecules 24 04204 g003
Figure 4. N,N′-diacetyllactosediamine (GalNAcβ1-4GlcNAc, LacDiNac).
Figure 4. N,N′-diacetyllactosediamine (GalNAcβ1-4GlcNAc, LacDiNac).
Molecules 24 04204 g004
Figure 5. LacDiNAc bound to CNL (PDB ID 3NBE). Hydrogen bonds are shown as orange dashed lines and the amino acid residues involved in their formation are labeled. (a) 3D representation of the CNL carbohydrate-binding pocket. (b) A schematic representation of the CNL interaction with LacDiNAc generated by LIGPLOT [29]. Black, red and blue circles represent carbon, oxygen and nitrogen atoms, respectively, with green bonds in the amino acid residues and cyan bonds in the LacDiNAc ligand. Water molecules are represented by light blue circles. The spiked atoms are those involved in hydrophobic contacts and the spiked circle segments surround hydrophobic van der Waals partners.
Figure 5. LacDiNAc bound to CNL (PDB ID 3NBE). Hydrogen bonds are shown as orange dashed lines and the amino acid residues involved in their formation are labeled. (a) 3D representation of the CNL carbohydrate-binding pocket. (b) A schematic representation of the CNL interaction with LacDiNAc generated by LIGPLOT [29]. Black, red and blue circles represent carbon, oxygen and nitrogen atoms, respectively, with green bonds in the amino acid residues and cyan bonds in the LacDiNAc ligand. Water molecules are represented by light blue circles. The spiked atoms are those involved in hydrophobic contacts and the spiked circle segments surround hydrophobic van der Waals partners.
Molecules 24 04204 g005
Figure 6. Proposed mechanism of CNL action. The bivalent carbohydrate-binding property of CNL, leading to the signal transduction pathway, is essential in both human leukemic T-cell specific cytotoxicity (left) and invertebrate toxicity (right).
Figure 6. Proposed mechanism of CNL action. The bivalent carbohydrate-binding property of CNL, leading to the signal transduction pathway, is essential in both human leukemic T-cell specific cytotoxicity (left) and invertebrate toxicity (right).
Molecules 24 04204 g006
Table 1. Glycan-binding specificity of Clitocybe nebularis lectin (CNL) determined by glycan microarray analysis. Specificity was defined using concentration-dependent binding of the lectin to glycan microarrays at different concentrations using mammalian printed array version 5.0 consisting of 611 glycan structures available at the Consortium for Functional Glycomics. The top 15 glycans showing highest affinities for CNL are shown [4]. Schematic representation of glycans was prepared by DrawGlycan-SNFG (http://www.virtualglycome.org/DrawGlycan/).
Table 1. Glycan-binding specificity of Clitocybe nebularis lectin (CNL) determined by glycan microarray analysis. Specificity was defined using concentration-dependent binding of the lectin to glycan microarrays at different concentrations using mammalian printed array version 5.0 consisting of 611 glycan structures available at the Consortium for Functional Glycomics. The top 15 glycans showing highest affinities for CNL are shown [4]. Schematic representation of glycans was prepared by DrawGlycan-SNFG (http://www.virtualglycome.org/DrawGlycan/).
CNL Binding Glycans 1Schematic Representation of Glycan Using the Symbolic Nomenclature for Glycans
GalNAcβ1-4GlcNAcβ1-3GalNAcβ1-4GlcNAcβ-sp 2 Molecules 24 04204 i001
GalNAcβ1-4GlcNAcβ-sp Molecules 24 04204 i002
(6S)GalNAcβ1-4GlcNAcβ-sp Molecules 24 04204 i003
GalNAcβ1-4GlcNAcβ-sp Molecules 24 04204 i004
GalNAcβ1-4GlcNAcβ1-2Manα-sp Molecules 24 04204 i005
GalNAcβ1-4(6S)GlcNAcβ-sp Molecules 24 04204 i006
GalNAcβ1-3GlcNAcβ-sp Molecules 24 04204 i007
GalNAcα1-3[Fucα1-2]Galβ-sp Molecules 24 04204 i008
GalNAcα1-3[Fucα1-2]Galβ1-4GlcNAcβ1-2Manα1-6[GalNAcα1-3[Fucα1-2]Galβ1-4GlcNAcβ1-2Manα1-3]Manβ1-4GlcNAcβ1-4GlcNAcβ-sp Molecules 24 04204 i009
GalNAcα1-3[Fucα1-2]Galβ1-4GlcNAcβ-sp Molecules 24 04204 i010
GalNAcβ-sp Molecules 24 04204 i011
GalNAcα1-3[Fucα1-2]Galβ1-4GlcNAcβ1-2Manα-sp Molecules 24 04204 i012
GalNAcα1-3[Fucα1-2]Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glc-sp Molecules 24 04204 i013
GalNAcα1-3[Fucα1-2]Galβ1-3GlcNAcβ1-2Manα1-6[GalNAcα1-3[Fucα1-2]Galβ1-3GlcNAcβ1-2Manα1-3]Manβ1-4GlcNAcβ1-4GlcNAcβ-sp Molecules 24 04204 i014
GalNAcα1-3[Fucα1-2]Galβ-sp Molecules 24 04204 i015
1 CNL binding to the Mammalian printed array version 5.0 at the Consortium for Functional Glycomics was assayed at 10, 1, and 0.1 μg/mL and a rank was determined for each glycan at each concentration. This list represents the top 15 glycans based on average ranks. 2 sp spacer.

Share and Cite

MDPI and ACS Style

Sabotič, J.; Kos, J. CNL–Clitocybe nebularis Lectin—The Fungal GalNAcβ1-4GlcNAc-Binding Lectin. Molecules 2019, 24, 4204. https://doi.org/10.3390/molecules24234204

AMA Style

Sabotič J, Kos J. CNL–Clitocybe nebularis Lectin—The Fungal GalNAcβ1-4GlcNAc-Binding Lectin. Molecules. 2019; 24(23):4204. https://doi.org/10.3390/molecules24234204

Chicago/Turabian Style

Sabotič, Jerica, and Janko Kos. 2019. "CNL–Clitocybe nebularis Lectin—The Fungal GalNAcβ1-4GlcNAc-Binding Lectin" Molecules 24, no. 23: 4204. https://doi.org/10.3390/molecules24234204

Article Metrics

Back to TopTop